Unichem Laboratories is currently trading at Rs. 194.80, up by 3.55 points or 1.86% from its previous closing of Rs. 191.25 on the BSE.
The scrip opened at Rs. 198.05 and has touched a high and low of Rs. 198.05 and Rs. 194.20 respectively. So far 12760 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 382.00 on 08-Jan-2018 and a 52 week low of Rs. 182.00 on 11-Oct-2018.
Last one week high and low of the scrip stood at Rs. 199.70 and Rs. 188.75 respectively. The current market cap of the company is Rs. 1367.55 crore.
The promoters holding in the company stood at 50.67%, while Institutions and Non-Institutions held 10.22% and 39.11% respectively.
Unichem Laboratories has received Tentative Approval for its Abbreviated New Drug Application (ANDA), Tadalafil Tablets, 2.5 mg, 5 mg 10 mg and 20 mg from the United States Food and Drug Administration (USFDA) for a generic version of ELI LILLY's Cialis, 2.5 mg, 5 mg, 10 mg and 20 mg.
The company's Tadalafil Tablets are indicated for the treatment of erectile dysfunction (ED) and treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) and the treatment of ED and the signs and symptoms of BPH (ED/BPH).
Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1829.70 |
Dr. Reddys Lab | 1377.30 |
Cipla | 1492.40 |
Lupin | 2269.20 |
Zydus Lifesciences | 1020.25 |
View more.. |